Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using
exemestane plus bicalutamide may fight prostate cancer by reducing the production of
androgens. It is not yet known if exemestane is more effective with or without bicalutamide
in treating prostate cancer.
PURPOSE: Randomized phase II trial to study the effectiveness of exemestane with or without
bicalutamide in treating patients who have stage IV prostate cancer that has been previously
treated with hormone therapy or surgery.